Octopus Ventures led the Series A round with support from TX Ventures and Solano Partners to drive international growth and product development.
"We’ve been impressed by the power of Swiipr’s offering to fundamentally transform compensation payments, delivering the scale and efficiency of modern payments to the airline industry while significantly improving the travel experience for their customers."
Parkwalk Advisors spearheaded the round to help the medical technology company prepare for human trials.
"With the support of our investors, we are on the cusp of revolutionising brain aneurysm treatment. Our team is dedicated to working with regulators, medical professionals, and industry experts to bring this product to market and address a condition impacting countless individuals worldwide."